Seller record · Telehealth service

Somi Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The answers and the about page refer to partner 503A pharmacies, and the terms to a pharmacy network the buyer may choose from. 2 more criteria also fail; see the table below.

At a glance

Somi HealthTelehealth service

5/8criteria passed

Price: Semaglutide $249 a month, tirzepatide $449; lower figures on three-month plans
Sells: compounded semaglutide, compounded tirzepatide, semaglutide tablets, and 6 more
FDA letters: None on file

Visit Somi Health See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A North Carolina telehealth platform selling compounded semaglutide and tirzepatide and semaglutide tablets, with NAD+, sermorelin, glutathione and sexual health, hair and skin treatments. Its pages print three different sets of GLP-1 prices, no page says a compounded drug is not FDA-approved, and no pharmacy is named.

Operating entity Somi Health LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Somi Health's website; Somi Health's how it works page
S2	Prescription gating	PASS	Somi Health's website; Somi Health's how it works page
S3	Pharmacy identification	FAIL	Somi Health's website; Somi Health's about page; Somi Health's terms of use page
S4	Compounding disclosure	FAIL	Somi Health's website; Somi Health's weight loss page; Somi Health's terms of use page
S5	Analytical documentation	FAIL	Somi Health's weight loss page; Somi Health's about page; Somi Health's terms of use page
S6	Business address	PASS	Somi Health's HIPAA privacy page; Somi Health's terms of use page
S7	Price disclosure	PASS	Somi Health's weight loss page; Somi Health's website; Somi Health's how it works page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA U.S.-licensed provider reviews each intake form, confirms eligibility and builds the treatment plan before a prescription is sent to the pharmacy.Source: Somi Health's website; Somi Health's how it works page.

S2PASSThe home and process pages list a brief medical intake form as the first step, reviewed by a licensed provider before approval, and the answers say the provider reviews the questionnaire to decide eligibility.Source: Somi Health's website; Somi Health's how it works page.

S3FAILNo filling pharmacy is named. The answers and the about page refer to partner 503A pharmacies, and the terms to a pharmacy network the buyer may choose from.Source: Somi Health's website; Somi Health's about page; Somi Health's terms of use page.

S4FAILNo page states that a compounded drug is not FDA-approved. The answers on the home page say compounded semaglutide and tirzepatide are clinically proven to be safe and effective, and the weight-loss page describes custom compounds from accredited partner pharmacies.Source: Somi Health's website; Somi Health's weight loss page; Somi Health's terms of use page.

S5FAILNo certificate of analysis or lot document is published on the weight-loss, longevity, process or about pages or in the terms.Source: Somi Health's weight loss page; Somi Health's about page; Somi Health's terms of use page.

S6PASS4111 E Rose Lake Dr, Charlotte, NC 28217, printed as the privacy contact address in the notice of privacy practices. The terms name North Carolina law.Source: Somi Health's HIPAA privacy page; Somi Health's terms of use page.

S7PASSThe weight-loss page prints semaglutide at $249 a month and tirzepatide at $449 a month. The home page prints three-month plans starting at $135 a month for semaglutide and $165 for tirzepatide at any dose, and semaglutide tablets from $279 a month on a one-month plan. The process page prints compounded semaglutide as low as $116 and tirzepatide as low as $199.Source: Somi Health's weight loss page; Somi Health's website; Somi Health's how it works page.

S8PASSNo FDA warning letter names Somi Health or Somi Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, semaglutide tablets, NAD+, sermorelin, glutathione, MIC + B12, tadalafil and sildenafil, minoxidil and finasteride.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Visit Somi Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.